A paramedic with a history of PTSD presents with symptoms of comorbid depression, including persistent low mood and anhedonia. Her vital signs show elevated blood pressure and heart rate, and she has elevated cortisol levels. The clinical team initiates cognitive-behavioral therapy (CBT) and continues to monitor her response to treatment. What is the primary nursing intervention to support this patient in managing her symptoms effectively?

A) Encourage daily physical activity to reduce sympathetic activation and improve mood.

B) Recommend a high-protein diet to stabilize cortisol levels and improve concentration.

C) Suggest limiting fluid intake to manage elevated blood pressure and heart rate.

D) Advise the patient to take over-the-counter sleep aids to improve sleep quality.

A paramedic with PTSD and newly developed comorbid depression is experiencing elevated blood pressure and heart rate, with laboratory tests showing increased cortisol levels. Cognitive-behavioral therapy (CBT) has been initiated alongside her current pharmacological treatment. Which nursing intervention is most appropriate to address her current symptoms and support her treatment plan?

B) Educate the patient on relaxation techniques to manage stress and sympathetic activation.

A) Encourage the patient to increase physical activity to lower cortisol levels.

B) Educate the patient on relaxation techniques to manage stress and sympathetic activation.

C) Suggest reducing caffeine intake to decrease blood pressure and heart rate.

D) Recommend the patient to monitor her blood pressure and heart rate daily.

A paramedic is undergoing treatment for PTSD with cognitive-behavioral therapy and is about to start an antidepressant due to persistent depressive symptoms and sympathetic nervous system activation. Which nursing intervention is most critical to prioritize when initiating the new antidepressant therapy?

A) Monitor the patient for any emergence of suicidal ideation, especially during the initial weeks of antidepressant therapy.

B) Educate the patient on the importance of maintaining a consistent exercise regimen to improve cardiovascular health.

C) Encourage the patient to keep a sleep journal to monitor changes in sleep patterns and dreams.

D) Schedule weekly weight checks to monitor for potential weight gain associated with antidepressant use.

A paramedic undergoing treatment for PTSD and comorbid depression is showing persistent depressive symptoms and signs of sympathetic nervous system activation, including elevated blood pressure and heart rate despite cognitive-behavioral therapy. The clinical team is considering the introduction of an antidepressant. Which of the following actions should the nurse prioritize to enhance the patient's treatment outcomes?

B) Monitor the patient's blood pressure and heart rate regularly to assess for cardiovascular changes.

A) Educate the patient about the potential side effects of the new antidepressant.

B) Monitor the patient's blood pressure and heart rate regularly to assess for cardiovascular changes.

C) Encourage the patient to increase physical activity to help manage depressive symptoms.

D) Coordinate with the healthcare provider to evaluate the effectiveness of the CBT sessions.

A paramedic on an integrated treatment approach for depression and PTSD presents with persistent cardiovascular symptoms, new-onset headaches, and elevated cortisol levels. Which nursing intervention is most appropriate to address these findings while awaiting further cardiologist evaluation?

B) Educate the patient on mindfulness-based stress reduction techniques to help manage anxiety and stress.

A) Increase the dosage of the current antidepressant to manage symptoms more effectively.

B) Educate the patient on mindfulness-based stress reduction techniques to help manage anxiety and stress.

C) Restrict the patient's fluid intake to control blood pressure levels.

D) Recommend complete cessation of the antidepressant until cardiovascular symptoms are evaluated.

A paramedic on an antidepressant regimen for depression and PTSD shows a mixed response in her symptoms. She presents with new complications including headaches, elevated blood pressure, and increased heart rate. What is the most appropriate initial nursing intervention to address this situation?

C) Collaborate with the healthcare team to review her current medication regimen and assess for possible side effects contributing to her symptoms.

A) Advise the patient to discontinue the antidepressant immediately to prevent further cardiovascular complications.

B) Educate the patient on lifestyle modifications such as diet and exercise to help manage her lipid levels and blood pressure.

C) Collaborate with the healthcare team to review her current medication regimen and assess for possible side effects contributing to her symptoms.

D) Refer the patient to a mindfulness-based stress reduction program to help manage her anxiety and stress response.

A paramedic undergoing treatment for PTSD is participating in a mindfulness-based stress reduction (MBSR) program alongside pharmacotherapy. She reports a mild reduction in anxiety and improved control over trauma-related stimuli. What should the nurse prioritize when evaluating the effectiveness of this integrated treatment approach?

A) Monitoring for further reduction in blood pressure and heart rate.

B) Assessing the patient's adherence to dietary modifications for lipid control.

C) Evaluating the willingness of the patient to continue the MBSR program.

D) Reassessing the patient's medication regimen for side effect management.

A paramedic undergoing treatment for PTSD is experiencing mild improvements in anxiety and cardiovascular status following the integration of mindfulness-based stress reduction (MBSR) into her care plan. However, she still reports occasional headaches and dizziness, which are suspected to be side effects of her current antidepressant. After reassessing her medication regimen, the healthcare team decides to switch her antidepressant. What nursing action is most appropriate to ensure the effectiveness and safety of this change in medication?

A) Educate the patient on potential withdrawal symptoms from the current antidepressant.

B) Advise the patient to discontinue the current antidepressant immediately before starting the new one.

C) Monitor the patient's blood pressure and heart rate daily for the first week after starting the new medication.

D) Instruct the patient to increase her physical activity level immediately to counteract cardiovascular risks.

A patient with PTSD and hypertension begins to experience gastrointestinal discomfort after starting a lipid-lowering agent. Which nursing intervention would be most appropriate to address the patient's new symptoms while maintaining the effectiveness of her cardiovascular treatment?

C) Advise taking the lipid-lowering agent with meals and adjusting the dosage.

A) Discontinue the lipid-lowering agent and monitor cardiovascular status.

B) Administer an antiemetic to manage nausea before meals.

C) Advise taking the lipid-lowering agent with meals and adjusting the dosage.

D) Increase dietary fiber intake to alleviate abdominal discomfort.

A patient undergoing treatment for PTSD and hyperlipidemia reports new symptoms of gastrointestinal discomfort after starting lipid-lowering agents. Which nursing intervention is the most appropriate to address the patient's symptoms while maintaining effective management of her lipid levels?

A) Advise the patient to take lipid-lowering medications with meals to minimize gastrointestinal upset.

B) Suggest the patient to discontinue the lipid-lowering agents until symptoms resolve.

C) Recommend increasing the dosage of lipid-lowering agents to achieve faster cholesterol reduction.

D) Encourage the patient to increase fiber intake significantly to mitigate gastrointestinal symptoms.

post traumatic stress disorder - Nursing Case Study

Pathophysiology

• Primary mechanism: Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis leads to altered cortisol levels. This affects the body's stress response, causing heightened arousal and difficulty in managing stress, which are central to PTSD symptoms.

• Secondary mechanism: Hyperactivity of the amygdala, a brain region involved in fear processing, coupled with reduced function of the prefrontal cortex, which is responsible for regulating emotions and enabling rational thought. This imbalance leads to exaggerated fear responses and impaired emotional regulation.

• Key complication: Chronic PTSD can result in increased risk for comorbid conditions such as depression and anxiety, due to persistent neurochemical changes and stress system dysfunction, affecting overall physical and mental health.

Patient Profile

Demographics:

32-year-old female, paramedic

History:

• Key past medical history: Witnessed and survived a severe vehicular accident one year ago

• Current medications: Sertraline 50 mg daily, prn use of lorazepam 0.5 mg for anxiety

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing anxiety and flashbacks related to the accident

• Key symptoms: Nightmares, hypervigilance, avoidance of driving, irritability, and occasional intrusive thoughts

• Vital signs: Blood pressure 145/92 mmHg, heart rate 102 bpm, respiratory rate 24 breaths per minute, temperature 98.6°F

Section 1

New Complications:

As the paramedic continues her journey with post-traumatic stress disorder, she begins to exhibit signs of developing comorbid depression. Over the past month, her symptoms have evolved; she reports a persistent low mood, loss of interest in activities she once enjoyed, and increasing fatigue, which has compounded her existing PTSD symptoms. During her latest assessment, she expresses feelings of hopelessness and notes experiencing difficulty concentrating, which has begun to affect her performance at work. Her sleep disturbances have worsened, with nightmares occurring more frequently, further exacerbating her irritability and emotional instability.

A comprehensive evaluation reveals that her blood pressure remains elevated at 148/95 mmHg, and her heart rate is consistently elevated, now averaging 110 bpm. These findings suggest an ongoing sympathetic nervous system activation, likely a result of compounded stress and emotional dysregulation. Laboratory tests show slight elevations in cortisol levels, indicative of continued HPA axis dysregulation. The patient's mental health team decides to initiate cognitive-behavioral therapy (CBT) to address both PTSD and depressive symptoms, alongside her current pharmacological treatment. The aim is to help her develop coping strategies and cognitive restructuring techniques to manage intrusive thoughts and mood symptoms.

As the clinical team monitors her response to these interventions, they remain vigilant for potential medication adjustments. The introduction of an antidepressant may be considered if depressive symptoms do not improve with CBT. Meanwhile, regular follow-ups are scheduled to assess her mental and physical health status, ensuring that any additional complications are identified and managed promptly. This approach underscores the importance of integrated care in managing complex PTSD cases with emerging comorbidities.

Section 2

Change in Patient Status:

Over the following weeks, the paramedic's response to the implemented cognitive-behavioral therapy (CBT) and her current medication regimen is closely monitored. Initially, she shows some improvement in managing her PTSD symptoms; she reports a slight decrease in the frequency and intensity of her nightmares, and her ability to recognize and challenge intrusive thoughts has enhanced. However, her depressive symptoms remain persistent, and she continues to experience a low mood and lack of motivation, which affects her engagement in therapy and daily activities.

During her most recent follow-up appointment, clinical evaluation reveals that her physical health indicators have not improved significantly. Her blood pressure has increased slightly to 152/98 mmHg, and her heart rate continues to average around 112 bpm. These persistent cardiovascular symptoms suggest that the stress-related activation of her sympathetic nervous system remains uncontrolled. Additionally, her cortisol levels remain elevated, indicating ongoing HPA axis dysregulation. Given the lack of significant improvement in her depressive symptoms and the continued sympathetic nervous system activation, the mental health team considers initiating an antidepressant to better address her comorbid depression alongside sustained cognitive-behavioral strategies.

The decision to introduce an antidepressant is made to complement the existing therapeutic measures, focusing on attenuating her depressive symptoms and potentially aiding in the regulation of her stress response. The clinical team continues to emphasize the importance of an integrated approach, ensuring that adjustments to her treatment plan are made promptly based on her evolving clinical status. Regular monitoring remains crucial, with an emphasis on evaluating both her mental and physical health, as these interconnected aspects significantly influence her overall recovery trajectory.

Section 3

Two weeks after initiating the antidepressant regimen, the paramedic returns for a follow-up evaluation. During this visit, her mental health team notes a mixed response to the intervention. Although her depressive symptoms have shown some improvement, as evidenced by her self-report of increased motivation and a slight elevation in mood, her PTSD symptoms have not seen a corresponding decrease. She continues to experience frequent flashbacks and heightened anxiety, particularly when exposed to stimuli reminiscent of traumatic events. This reflects a partial but incomplete response to the integrated treatment approach, necessitating further clinical reasoning to optimize her care.

Her physical assessment reveals concerning new complications. She reports experiencing frequent headaches, which she describes as throbbing and accompanied by occasional dizziness. Upon examination, her blood pressure has further increased to 160/100 mmHg, and her heart rate remains elevated at 108 bpm. Laboratory tests reveal persistently elevated cortisol levels, suggesting that her stress response remains inadequately managed. Additionally, a lipid panel indicates elevated LDL cholesterol and triglycerides, raising concerns about her cardiovascular risk profile given her ongoing hypertension and tachycardia.

These findings prompt the healthcare team to reassess her treatment plan. The persistent cardiovascular symptoms and new onset of headaches could be indicative of either a side effect from the antidepressant or an unresolved aspect of her stress response. The team considers the need for a comprehensive review of her medication regimen and potential referral to a cardiologist for further evaluation. Meanwhile, they explore the possibility of integrating supplementary therapies, such as mindfulness-based stress reduction, to address her persistent anxiety and autonomic dysregulation. The focus remains on a holistic approach, with careful monitoring of her evolving clinical status to guide further interventions.

Section 4

As the mental health team evaluates the paramedic's progress, they decide to focus on the integration of mindfulness-based stress reduction (MBSR) into her treatment plan, alongside the ongoing pharmacotherapy. The patient participates in a structured MBSR program, which includes guided meditation sessions and breathing exercises designed to reduce her autonomic dysregulation and manage anxiety. Over the next two weeks, the team monitors her closely for changes in her PTSD symptoms and cardiovascular indicators.

During a subsequent follow-up visit, the patient reports a mild reduction in anxiety levels and notes that she feels more in control when exposed to trauma-related stimuli. Her blood pressure has slightly decreased to 150/95 mmHg, and her heart rate is now 98 bpm, suggesting a modest improvement in her cardiovascular status. However, she continues to experience occasional headaches and dizziness, prompting further evaluation. Reassessment of her medication regimen reveals that her current antidepressant may be contributing to these symptoms. The healthcare team decides to adjust her medication, opting for an alternative with a more favorable side effect profile for managing both depressive and anxiety symptoms.

Laboratory tests conducted at this follow-up show a slight reduction in cortisol levels, indicating a potentially positive response to the MBSR program. However, her lipid panel remains concerning, with LDL cholesterol at 160 mg/dL and triglycerides at 210 mg/dL. Recognizing the importance of addressing her cardiovascular risk, the team discusses dietary modifications and the possible introduction of lipid-lowering agents. The ongoing assessment and tailored interventions aim to achieve a balanced approach, improving her mental and physical health while reducing the risks associated with her PTSD and comorbid conditions.

Section 5

In the following weeks, the patient continues with the mindfulness-based stress reduction (MBSR) program and adheres to the modified medication regimen. During a routine follow-up, she reports feeling more grounded and experiences fewer intrusive thoughts and nightmares. Her blood pressure has further improved to 140/90 mmHg, and her heart rate is now 92 bpm, indicating a positive trend in cardiovascular function. However, despite these improvements, she begins to experience new symptoms of gastrointestinal discomfort, including nausea and occasional abdominal pain. These issues are unexpected, given her current treatment plan, prompting the healthcare team to investigate further.

Upon reviewing her dietary habits and medication usage, it is discovered that the introduction of lipid-lowering agents may be contributing to her gastrointestinal symptoms. A decision is made to modify the dosage and timing of these medications while continuing dietary counseling to help manage her lipid levels. Meanwhile, her latest laboratory results reveal a reduction in LDL cholesterol to 145 mg/dL and triglycerides to 180 mg/dL, reflecting a modest but significant improvement. The team remains vigilant in monitoring her response to these changes, recognizing the delicate balance required to manage her PTSD symptoms, cardiovascular health, and now emerging gastrointestinal concerns.

As she navigates these challenges, the mental health team considers integrating additional therapeutic interventions to address her evolving needs. They explore options such as cognitive behavioral therapy (CBT) to further enhance her coping mechanisms and resilience. The ongoing collaborative care plan aims to provide comprehensive support, acknowledging the interconnectedness of her mental and physical health needs. By carefully adjusting interventions and maintaining open communication, the healthcare team strives to empower the patient in her recovery journey, fostering a holistic approach that addresses both immediate symptoms and long-term well-being.